Bitcoin Completes Fourth Halving, Snutx Exchange Sees New Investment Surge

Bitcoin Completes Fourth Halving, Snutx Exchange Sees New Investment Surge

On April 20, Bitcoin successfully completed its fourth halving, marking another significant turning point in the global cryptocurrency market. This halving event garnered widespread attention and had a direct impact on the market. As of now, the price of Bitcoin stands at $63,914 per coin, showing a slight increase from pre-halving levels. This trend once again...

Read More

Boeing chair to meet key airline customers without planemaker\'s CEO, sources say

By David Shepardson and Rajesh Kumar Singh WASHINGTON/CHICAGO (Reuters) -Major airline chiefs plan to hold discussions with Boeing (NYSE:BA) board chair Larry Kellner in meetings that will not include CEO David Calhoun after raising concerns over an Alaska Airlines mid-air emergency and ongoing production issues, sources said. A group of U.S. airline CEOs sought meetings...

Read More

Australia Leading Index Data Due On Wednesday

Australia will on Wednesday see February results for the leading economic index from the Melbourne Institute, highlighting a light day for Asia-Pacific economic activity. In January, the index slipped 0.1 percent on month. New Zealand will see March results for the business confidence index from ANZ Bank and the business activity index from NBNZ; in...

Read More

Hacker forum post claims UnitedHealth paid $22 million ransom in bid to recover data

By Raphael Satter WASHINGTON (Reuters) - A post on a hacker forum popular with cybercriminals has claimed UnitedHealth Group (NYSE:UNH) paid $22 million in a bid to recover access to data and systems encrypted by the \"Blackcat\" ransomware gang, according to two researchers. Neither UnitedHealth nor the hackers involved have commented on the alleged ransom...

Read More

Ben Goertzel, CEO of SingularityNET, on the Exciting AI-Crypto Intersection, AI Launched on Decentralized Infra, and AI as New Species Smarter Than Humans | Ep. 364

Crypto is now a store of value and a financial speculation instrument, but there is no “kick-ass mainstream use case that we want.” The next evolution of AI could become that use case, said Goertzel. Hence, the team is looking into ways to launch the next AI evolution on the ASI infrastructure. Certain useful elements...

Read More

J&J Seeks EMA Approval For DARZALEX Quadruplet Therapy For Multiple Myeloma

Janssen-Cilag International NV, a Johnson & Johnson company (JNJ), announced Wednesday the submission of a Type II variation application to the European Medicines Agency (EMA). The submission is seeking approval for an indication extension of DARZALEX (daratumumab) subcutaneous (SC) formulation in combination with bortezomib, lenalidomide, and dexamethasone (D-VRd) for the treatment of adult patients with...

Read More

FDA fast tracks epcoritamab for follicular lymphoma

COPENHAGEN - The U.S. Food and Drug Administration (FDA) has granted Priority Review for epcoritamab, a potential new treatment for patients with relapsed or refractory follicular lymphoma, announced Genmab A/S (NASDAQ: NASDAQ:GMAB) and AbbVie (NYSE: NYSE:ABBV). This designation could significantly expedite the therapy\'s approval process, with a target action date set for June 28, 2024....

Read More

Griffon Boost FY24 Revenue Outlook - Update

While reporting financial results for the second quarter on Wednesday, Griffon Corp. (GFF) raised its revenue expectation for the full-year 2024 to $2.65 billion from the prior guidance of $2.6 billion. On average, five analysts polled by Thomson Reuters expect the company to report revenues of $2.63 billion for the year. Separately, the Board of...

Read More